Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.

NCT ID: NCT03895008

Last Updated: 2019-07-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-08

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To comparing the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to compare the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.In this study, patients with cardiac and non-cardiac gastric cancer who undergo radical resection from January 2019 to December 2024 will be included. We will follow up the patient's progression, recurrence time and survival time.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cardia gastric cancer

Cardiac gastric cancer is defined as a cancer center lies arising 2-5 cm from the gastric mucosa distal to the esophagogastric junction.

Cardia and Non-cardia gastric cancer

Intervention Type OTHER

We classify gastric cancer into cardia gastric cancer and non-cardia gastric cancer.

Non-cardia gastric cancer

Non-cardia gastric cancer is defined as tumors originated from the gastric mucosa distal to the cardia.

Cardia and Non-cardia gastric cancer

Intervention Type OTHER

We classify gastric cancer into cardia gastric cancer and non-cardia gastric cancer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardia and Non-cardia gastric cancer

We classify gastric cancer into cardia gastric cancer and non-cardia gastric cancer.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Histopathology or cytopathology proven cardia or non-cardia gastric cancer;
2. Operable gastric cancer patients: primary lesions can be completely excision, no distant metastasis;
3. Life expectancy of at least 6 months;
4. ECOG(Eastern Cooperative Oncology Group ) score 0-1;
5. Age: 18\~80 years old;
6. Normal hemodynamic indices before the recruitment (including blood cell count and liver/kidney function).

For example: WBC(White blood cell count )\>4.0×109/L; NEU(Neutrophils)\>1.5×109/L; PLT(Platelet)\>100×109/L;
7. Roughly normal cardiopulmonary function: No coronary heart disease, myocardial infarction, pulmonary heart disease, refractory hypertension;
8. Not concomitant with other uncontrollable benign diseases before the recruitment;
9. Voluntarily signed the informed consent.

Exclusion Criteria

1. Advanced gastric cancer patients with distant metastasis and inoperable ;
2. Pregnant or lactating women;
3. Patients who have no desire to participate in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Qinghai People's Hospital

OTHER

Sponsor Role collaborator

LanZhou University

OTHER

Sponsor Role collaborator

Affiliated Hospital of Qinghai University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jiuda Zhao

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Second Hospital of Lanzhou University

Lanzhou, Gansu, China

Site Status RECRUITING

Affiliated Hospital of Qinghai University

Xining, Qinghai, China

Site Status RECRUITING

People's Hospital of Qinghai Province

Xining, Qinghai, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jiuda Zhao, M.D.

Role: CONTACT

+869716162732

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Enxi Li

Role: primary

15809317472

Jiuda Zhao, M.D.

Role: primary

+869716162732

Jie Kan, M.D

Role: primary

+8613897584590

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AHQU-2019001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.